Chemoinformaics analysis of Methyl 2-methylhexadecanoate
| Molecular Weight | 284.484 | nRot | 14 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 1 |
| Exact Molecular Weight | 284.272 | nRing | 0 |
| Solubility: LogS | -6.746 | nHRing | 0 |
| Solubility: LogP | 7.409 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.6685 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.294 |
| Synth | 2.355 |
| Natural Product Likeliness | 0.471 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.034 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.767 |
| MDCK | 0.0000149 |
| BBB | 0.355 |
| PPB | 0.968745 |
| VDSS | 1.943 |
| FU | 0.020667 |
| CYP1A2-inh | 0.579 |
| CYP1A2-sub | 0.316 |
| CYP2c19-inh | 0.475 |
| CYP2c19-sub | 0.282 |
| CYP2c9-inh | 0.271 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.252 |
| CYP2d6-sub | 0.095 |
| CYP3a4-inh | 0.546 |
| CYP3a4-sub | 0.095 |
| CL | 5.017 |
| T12 | 0.107 |
| hERG | 0.233 |
| Ames | 0.006 |
| ROA | 0.025 |
| SkinSen | 0.951 |
| Carcinogencity | 0.043 |
| EI | 0.969 |
| Respiratory | 0.881 |
| NR-Aromatase | 0.083 |
| Antiviral | Yes |
| Prediction | 0.622228 |